LiquiTime^®

Avadel’s LiquiTime research and development services employ the competitive advantages of its Micropump^® technology to allow development of modified/controlled release liquid suspension formulations. Avadel’s LiquiTime services focus on products particularly suitable for dosing children and other patients having issues swallowing tablets or capsules. Unlike the development of resin-complex-based liquid pharmaceuticals, Avadel’s LiquiTime research/development services employ technologies that are not limited to ionic drugs and can be applied to the development of combination products.

Advantages of LiquiTime-developed products:

• Easy-to-swallow formulations
• Good mouthfeel
• Taste-masked
• Dosing flexibility